Safeguard Scientifics, Inc. (NYSE:SFE) has been given a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.

Analysts have set a 12 month consensus price target of $20.00 for the company and are forecasting that the company will post ($1.05) earnings per share for the current quarter, according to Zacks. Zacks has also given Safeguard Scientifics an industry rank of 119 out of 265 based on the ratings given to related companies.

SFE has been the topic of a number of recent research reports. BidaskClub upgraded shares of Safeguard Scientifics from a “hold” rating to a “buy” rating in a research note on Thursday, July 13th. Zacks Investment Research upgraded shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $16.00 price target on the stock in a research note on Thursday. Finally, ValuEngine upgraded shares of Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.

WARNING: “Analysts Set $20.00 Target Price for Safeguard Scientifics, Inc. (SFE)” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/11/03/analysts-set-20-00-target-price-for-safeguard-scientifics-inc-sfe.html.

Safeguard Scientifics (NYSE:SFE) last released its earnings results on Thursday, October 26th. The asset manager reported ($0.91) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($1.11) by $0.20. During the same quarter in the previous year, the business earned ($1.18) EPS.

Institutional investors have recently made changes to their positions in the business. American International Group Inc. increased its stake in Safeguard Scientifics by 7.2% in the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock valued at $158,000 after purchasing an additional 833 shares during the last quarter. KBC Group NV increased its stake in Safeguard Scientifics by 41.3% in the second quarter. KBC Group NV now owns 13,351 shares of the asset manager’s stock valued at $159,000 after purchasing an additional 3,904 shares during the last quarter. Nationwide Fund Advisors increased its stake in Safeguard Scientifics by 7.6% in the second quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock valued at $169,000 after purchasing an additional 1,006 shares during the last quarter. Alliancebernstein L.P. increased its stake in Safeguard Scientifics by 27.4% in the second quarter. Alliancebernstein L.P. now owns 14,430 shares of the asset manager’s stock valued at $172,000 after purchasing an additional 3,100 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Safeguard Scientifics by 12.9% in the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock valued at $195,000 after purchasing an additional 1,754 shares during the last quarter. Institutional investors own 77.57% of the company’s stock.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.